Published studies show hypermethylation of the promotor region and gene silencing as a potential mechanism underlying the repression of the SEMA3B expression in most malignancies, including lung adenocarcinoma (13, 47). The gene discussed is SEMA3B; the disease is lung adenocarcinoma.